Literature DB >> 26584482

Vaginal Pessary for Uterine Repositioning during High-Intensity Focused Ultrasound Ablation of Uterine Leiomyomas.

Tajana Klepac Pulanic1, Aradhana M Venkatesan, James Segars, Sham Sokka, Bradford J Wood, Pamela Stratton.   

Abstract

In order to ensure safe magnetic resonance-guided, high-intensity focused, ultrasound ablation of uterine leiomyomas, the ultrasound beam path should be free of intervening scar and bowel. Pre-treatment MRI of a 9-cm long and 7.7-cm wide leiomyomatous uterus in a 39-year-old woman with menorrhagia and abdominopelvic pain initially demonstrated a focused ultrasound treatment path without a bowel between the uterus and the abdominal wall. On the day of ablation, however, multiple loops of bowel were observed in the ultrasound beam path by MRI. Uterine repositioning was accomplished with a 76-mm donut vaginal pessary, which anteverted the fundus and successfully displaced the bowel. A vaginal pessary may aid in repositioning an axial or retroverted uterus to enable ablation of uterine leiomyomas.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26584482      PMCID: PMC4864147          DOI: 10.1159/000441782

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  16 in total

1.  FDA approves ultrasound fibroid therapy.

Authors:  Sarah Ringold
Journal:  JAMA       Date:  2004-12-15       Impact factor: 56.272

2.  Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results.

Authors:  V Froeling; K Meckelburg; N F Schreiter; C Scheurig-Muenkler; J Kamp; M H Maurer; A Beck; B Hamm; T J Kroencke
Journal:  Eur J Radiol       Date:  2013-09-03       Impact factor: 3.528

3.  Comparison of the perinatal outcomes after laparoscopic myomectomy versus abdominal myomectomy.

Authors:  Mamiko Fukuda; Tomohito Tanaka; Mika Kamada; Atsushi Hayashi; Yoshiki Yamashita; Yoshito Terai; Masahide Ohmichi
Journal:  Gynecol Obstet Invest       Date:  2013-10-01       Impact factor: 2.031

Review 4.  The history and usage of the vaginal pessary: a review.

Authors:  Reeba Oliver; Ranee Thakar; Abdul H Sultan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-01-21       Impact factor: 2.435

Review 5.  Combined oral contraceptive for treatment of women with uterine fibroids and abnormal uterine bleeding: a systematic review.

Authors:  Rafael M Moroni; Wellington P Martins; Sabrine V Dias; Carolina S Vieira; Rui A Ferriani; Carolina O Nastri; Luiz Gustavo Brito
Journal:  Gynecol Obstet Invest       Date:  2015-02-06       Impact factor: 2.031

6.  Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology.

Authors:  Aradhana M Venkatesan; Ari Partanen; Tajana Klepac Pulanic; Matthew R Dreher; John Fischer; Robert K Zurawin; Raja Muthupillai; Sham Sokka; Heikki J Nieminen; Ninet Sinaii; Maria Merino; Bradford J Wood; Pamela Stratton
Journal:  J Vasc Interv Radiol       Date:  2012-06       Impact factor: 3.464

Review 7.  Uterine leiomyomas: individualizing the approach to a heterogeneous condition.

Authors:  Shannon K Laughlin; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

8.  Do patients prefer a pessary or surgery as primary treatment for pelvic organ prolapse.

Authors:  S D Thys; J P Roovers; P M Geomini; M Y Bongers
Journal:  Gynecol Obstet Invest       Date:  2012-06-28       Impact factor: 2.031

Review 9.  Current concepts in uterine fibroid embolization.

Authors:  Julie C Bulman; Susan M Ascher; James B Spies
Journal:  Radiographics       Date:  2012-10       Impact factor: 5.333

10.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.